Clinical Trials Sponsored by GlycoVaxyn AG

Total 2342 results

Ivoclar Vivadent AG

Completed

Clinical Investigation on Zirconia-ceramic Three-unit Bridges With CAD-on Veneering

Three-unit Posterior Bridges

Switzerland
Institut Straumann AG

Completed

Emdogain Minimally Invasive Surgical Technique

Periodontitis

Germany, United States, Canada
Phonak AG, Switzerland

Unknown

Evaluation of New Custom Made Hearing Product Technology and Shell Modification (CPS)

Hearing Loss, Bilateral or Unilateral

Switzerland
Geistlich Pharma AG

Completed

Long-term Follow-up Observation After Surgical Treatment of Peri-implantitis in Multicenter Post Market Clinical Study

Peri-implantitis

Sweden
Institut Straumann AG

Completed

The Role of Immediate Provisional Restorations on Bone Level Implants

Jaw, Edentulous, Partially

United Kingdom
MetrioPharm AG
Parexel

Completed

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

Psoriasis | Plaque Psoriasis

Germany
Alvotech Swiss AG

Completed

Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers (ALVOPAD)

Healthy Volunteers

Australia
Sandoz
Hexal AG

Completed

Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis (ADMYRA)

Rheumatoid Arthritis

United States, United Kingdom, Hungary, Italy, Malaysia, Serbia, Mexico, Spain, Czechia, Poland, Germany, Romania, Russian Federation
Heidelberg Pharma AG

Completed

Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer

Kidney Cancer

United States, Canada, Argentina, Brazil
TRB Chemedica AG

Completed

Viscontour® Serum Med in Hydration of Facial Skin

Sodium Hyaluronate

Germany
Brust-Zentrum AG

Completed

SKINI - Radicality of Skin-Sparing and Nipple-Sparing Mastectomy (SKINI)

Surgery

Switzerland
Storz Medical AG

Completed

Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome (ESWT)

Plantar Fasciitis

United States
Institut Straumann AG

Completed

Straumann Roxolid Multi-Center Study

Jaw, Edentulous, Partially

United States
Heidelberg Pharma AG

Withdrawn

REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT

Kidney Cancer | Renal Cell Carcinoma

United States
Advanced Bionics AG

Completed

Evaluation of a Binaural Beamformer (StereoZoom) in a Virtual Acoustic Environment and in Real Life

Sensory Hearing Loss

Switzerland
Sandoz
Hexal AG

Completed

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

Anemia

Germany, Romania
Advanced Bionics AG

Completed

Benefits of a Contralateral Routing of Signals (CROS) System in Unilateral CI-recipients

Cochlear Implants

France
Tillotts Pharma AG

Completed

Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis

Ulcerative Colitis

Belarus, Turkey, India, Ukraine
Sandoz
Hexal AG

Completed

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira (ADACCESS)

Plaque Type Psoriasis

United States, France, Bulgaria, Slovakia
PIQUR Therapeutics AG

Completed

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309

Advanced Solid Tumors

Switzerland
Retina Implant AG

Completed

Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Retinal Degeneration | Retinitis Pigmentosa

Hong Kong
B.Braun Avitum AG

Completed

HELP Therapy for Dry AMD (HELPuc)

Non-exudative (Dry) Age-related Macular Degeneration (AMD)

Canada
Medical Park AG

Unknown

tDCS and Speech Therapy to Improve Aphasia (MP-LOGA)

Stroke | Transcranial Direct Current Stimulation | Speech Therapy | Aphasia, Global

Germany
Antia Therapeutics AG

Unknown

Prospective Study to Assess the Safety and Performance of the Easyx Antia Liquid Embolic in Intracranial Interventions (Ideale)

Arterial Embolization
Maquet Cardiopulmonary AG

Withdrawn

The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD) (PALP-COPD)

Chronic Obstructive Pulmonary Disease | COPD

Germany
Institut Straumann AG

Completed

Comparison of Early and Late Loading in the Edentulous Upper Jaw Using Cresco Prosthetic System on Straumann Implants

Jaw, Edentulous

Sweden
Institut Straumann AG

Terminated

Comparison of Straumann BoneCeramic vs. Allograft Bone in Extraction Sockets

Tooth Loss

United States
Institut Straumann AG

Withdrawn

A Comparative, Randomized, Prospective, Performance Evaluation of Abutments in Single Tooth Gaps

Tooth Loss

Switzerland
Institut Straumann AG

Completed

Comparison of Straumann Bone Ceramic and Bio-Oss With Guided Tissue Regeneration for Alveolar Ridge Preservation

Bone Loss

United Kingdom
Institut Straumann AG

Completed

Maxillary Sinus Elevation With Bio-Oss or Straumann BoneCeramic

Bone Loss | Teeth Loss

Italy
TME Pharma AG

Completed

First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94

Inflammation | Anemia | Chronic Diseases

United Kingdom
Azad Pharma AG

Completed

Bioequivalence Study With Pharmacokinetic Endpoints, Comparing a Single Dose of Iron Sucrose Azad Injection of Azad Pharma Corporation (AG), With a Single Dose of Venofer® Injection of Vifor Corporation (AG) in Healthy Adult Volunteers

Healthy Volunteers

Austria
Tillotts Pharma AG

Completed

TP0501 - Pharmaco-Scintigraphic-Study

Ulcerative Colitis
Tillotts Pharma AG

Completed

TP0502-Pharmaco-Scintigraphic-Study and Amendment

Ulcerative Colitis
TME Pharma AG

Completed

NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers (SNOXA12C101)

Hematopoietic Stem Cell Transplantation

Germany
Phonak AG, Switzerland

Completed

Post-market Study to Capture Information Regarding Performance of Lyric2

Hearing Loss

United States
Cytos Biotechnology AG

Terminated

CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma

Moderate to Severe Allergic Asthma

United States, Czech Republic, Germany, Hungary, Israel, Poland, Russian Federation, Ukraine
TME Pharma AG

Completed

NOX-E36 First-in-Human (FIH) Study

Type 2 Diabetes Mellitus | Systemic Lupus Erythematosus | Chronic Inflammatory Diseases
Hamilton Medical AG

Completed

Intellivent Versus Conventional Ventilation (Intellivent)

Respiratory Failure | Self Efficacy

Belgium
Cytos Biotechnology AG

Completed

Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQb

Essential Hypertension
Kuros Biosurgery AG

Withdrawn

Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts

Bone Cysts
Kuros Biosurgery AG

Completed

Safety and Efficacy of I 0401 in the Treatment of Tibial Plateau Fractures Requiring Grafting

Tibia Plateau Fractures

Australia, France, Germany, Hungary, Italy, Poland, Spain, Switzerland, United Kingdom
Axxonis Pharma AG

Completed

Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion

Parkinson's Disease

Germany
Axxonis Pharma AG

Completed

Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)

Restless Legs Syndrome

Germany
TRB Chemedica AG

Completed

Hyaluronan in the Treatment of Painful Tendinopathy

Tendinopathy

Germany
SkyePharma AG
Abbott

Completed

A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005

Asthma

United States, Ukraine, Mexico, Peru, Romania
Retina Implant AG

Completed

Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors

Retinitis Pigmentosa

Germany
Cytos Biotechnology AG

Completed

Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy

Rhinoconjunctivitis | Allergies

Estonia, Germany, Greece, Latvia, Lithuania, Romania
SkyePharma AG
Abbott

Completed

Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma

Mild to Moderate Asthma

United States
Cytos Biotechnology AG

Completed

Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Against Essential Hypertension

Hypertension

Switzerland, Germany

3

Subscribe